-
risk factors for hematologic malignancy development following curative therapies for sickle cell disease (SCD), under the mentorship of Dr. Courtney Fitzhugh. The Laboratory of Early Sickle
-
and resilience. This research will contribute to the discovery of novel risk genes, steer basic research and drug development, and advance personalized medicine. Required Qualifications: 1. Ph.D. in
Enter an email to receive alerts for risk "https:" positions